BridgeMD
New treatment option for Hematopoietic Cell Transplant
Official title Virtual Rehabilitation in HCT
ClinicalTrials.gov ID: NCT05943964
What this study is testing
- What it's testing
- Chronic GVHD (cGVHD) is a major cause of illness in patients who undergo hematopoietic transplantation (HCT). GVHD can affect any organ in the body, can require several years of treatment, and can impact the quality of life (QoL).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 23
You may be able to join if
- Recipients between the ages of 8 and 23 years ≥100 days post allogeneic HCT.
- Patients 8-14 years old should have a caregiver willing to assist with the implementation of the exercises during the session
- Patients should have access to devices and a reliable internet connection.
- Patients should be cleared for exercise by their physician
- Patients are eligible to participate regardless of underlying diagnosis, preparative regimen, or graft source.
You likely can't join if
- Any physical impediment to exercise as evaluated by the treating physician.
- Non-English-speaking patients (due to a lack of available interpreters through the telemedicine platform).
The study team makes the final eligibility decision.
Where it's taking place
- Atlanta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 23 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Atlanta, Georgia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.